Charlie O’Connell is the founder and CEO of FITSCRIPT: a digital therapeutics company dedicated to providing digital exercise therapy to people living with diabetes around the globe.
Fitscript’s patented and clinically validated GlucoseZone (glucosezone.com) offers patients A1c improvement and weight loss through digital exercise therapy based on their real time bio metrics and medication usage.
Fitscript is a company dedicated to providing on-demand and interactive multi-media guidance to the global diabetes community.
Thru June of 2019, over 1 million people living with diabetes around the world have utilized GLUCOSEZONE programming to reduce, manage, and control their diabetes.
Diagnosed with Type 1 diabetes in the fall of 1996, Charlie is a graduate of the University of Pennsylvania (’02). Charlie is a father, husband, golfer, skier, runner, speaker, inventor and entrepreneur, and lives in New Haven CT with his wife and two small children.